MarketPulse
E

$ESAIY

4 articles found
2 positive
0 negative
2 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

ESR1-Mutated Breast Cancer Market Set to Surge at 9.6% CAGR as Novel Therapies Transform Treatment

ESR1-mutated breast cancer market projected to grow 9.6% through 2036, reaching USD 1.5B in 2025, driven by novel SERD therapies and VEPPANU's PROTAC approval.
PFELLYRHHBYAZNOLMA+2clinical trialsmarket forecast
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Biogen's Three-Decade Winning Streak Under Pressure as Biosimilars Loom

Biogen's three-decade outperformance is challenged by biosimilar competition and weak growth, though new Alzheimer's and rare disease drugs offer hope. Success requires flawless execution.
BIIBESAIYbiotechrevenue growth
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Dementia Drug Market Poised for Expansion as Disease-Modifying Therapies Reshape Treatment Landscape

Global dementia market expanding rapidly as disease-modifying treatments like LEQEMBI and KISUNLA shift focus from symptom management to early intervention for 55 million affected patients worldwide.
LLYBIIBESAIYALECmarket forecastAlzheimer's disease
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

SLE Drug Race Heats Up: 120+ Pharma Giants Develop 140+ Pipeline Therapies

Over 120 pharmaceutical companies are developing 140+ drugs for systemic lupus erythematosus, with major players like Roche and Novartis advancing promising new treatment mechanisms.
JNJABBVNVSRHHBYAZN+3FDA approvalclinical trials